The growth of Nucleic Acid Isolation and Purification Market can mainly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. The emerging economies and improving regulatory & reimbursement scenario are expected to offer a wide range of growth opportunities for players in the nucleic acid purification market.
The Nucleic Acid Isolation and
Purification Market
is projected to reach USD 9.2 billion by
2027 from USD 6.3 billion in 2022, at a
CAGR of 7.9% during the forecast period.
Browse in-depth TOC on "Nucleic
Acid Isolation & Purification Market"
173 – Tables
36 – Figures
237 – Pages
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229978287
KEY MARKET DYNAMICS
1
DRIVERS
1
Increasing R&D activities
2
Technological advancements and increasing automation
2
RESTRAINTS
1
High cost of automated instruments
3
OPPORTUNITIES
1 High scope of growth in emerging economies
2 Improving regulatory and reimbursement scenario
3 Molecular diagnostics and personalized medicine
4
TRENDS
1
Increase in government funding
Market Segmentation :-
·
On the basis of product, the nucleic acid isolation
market has been segmented into kits, reagents, and instruments. The kits
segment accounted for the largest share of the global nucleic acid purification
market in 2021.
·
On the basis of application, the global nucleic acid
isolation and purification market is segmented into diagnostics, drug discovery
& development, personalized medicine, agriculture & animal research,
and other applications. The diagnostics segment is expected to grow at the
highest CAGR during the forecast period.
·
On the basis of type, the global nucleic acid
isolation and purification market is segmented into plasmid DNA isolation and
purification, total RNA isolation and purification, circulating nucleic acid
isolation and purification, genomic DNA isolation and purification, messenger
RNA isolation and purification, microRNA isolation and purification, PCR
cleanup, and other nucleic acid isolation and purification types.
Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=229978287
Regional
Analysis: -
In 2021, North
America accounted for the largest share of the nucleic
acid purification market, followed by Europe.
The large share of this region can be attributed to factors such as significant
R&D spending in biotechnology and pharmaceutical companies, the large size
of the biotechnology industry, technological advancements, and government
support in the region. With rapid development in molecular biotechnology, novel
detection techniques and molecular diagnostic represented by nucleic acid
hybridization and nucleic acid sequence analysis are becoming increasingly
significant in various medical fields. Hence, leading players in the market are
focusing on entering into a strategic collaboration to develop novel products.
For instance, in Market 2020, Zymo Research announced entering into
collaboration with, a laboratory instruments and solutions provider, Tecan to
launch ready-to-use processing products for streamlining DNA and RNA extraction
for nucleic acid hybridization. Such product launches are expected to
facilitate the growth in the North American region. However, the Asia Pacific region
is expected to grow at the highest rate during the forecast period.
Recent Developments
- In 2022, Thermo Fisher invested USD 97
million to expand its clinical research operations in Richmond, Virginia.
The facility will provide high-quality bioanalytical lab services to advance
clinical research programs.
- In 2021, Thermo acquired PPD, a leading
global provider of clinical research services to the biopharma and biotech
industry, advancing its clinical research services.
- In 2020, Merck invested EUR 18 million
(USD 21.09 million) to build a life sciences laboratory in Buchs,
Switzerland, to accelerate and support research & development,
analytical production, and quality control.
- In 2020, Thermo Fisher acquired QIAGEN
N.V., a leading global provider of molecular diagnostics and sample
preparation technologies. This acquisition is expected to expand the
company’s specialty diagnostics portfolio with innovative sample
preparation, assay, and bioinformatics technologies.
Top Key Players:-
The prominent players in this nucleic acid isolation
market are QIAGEN N.V. (Netherlands),
Thermo Fisher Scientific (US), F. Hoffmann-La Roche Ltd. (Switzerland),
Merck KGaA (Germany),
Bio-Rad Laboratories (US), Agilent Technologies (US), Danaher Corporation (US),
GE Healthcare (US), Illumina, Inc. (US), Takara
Bio (Japan),
Zymo Research (US), New England Biolabs (US), Norgen Biotek Corp (Canada),
and Omega Bio-tek
(US).
